Figure 5.

Association between the index of cortical remyelination and the probability of clinical progression after 5 years. (A) Predicted probabilities of clinical progression in the multiple sclerosis (MS) cohort characterized by a limited extent of cortical demyelination at baseline and a disease duration shorter than 5 years. (B) Predicted probabilities of clinical progression in the MS cohort characterized by an extent of cortical demyelination at baseline greater than 8.5% or a disease duration longer than 5 years.